文献
J-GLOBAL ID:201902235874737323
整理番号:19A0341021
EGFR変異陽性肺癌においてベバシズマブとエルロチニブ併用療法とエルロチニブ単剤療法の効果を比較する第三相試験(NEJ026)
Phase III study comparing bevacizumab plus erlotinib (BE) to erlotinib(E) for NSCLC with EGFR mutations (NEJ026)
著者 (15件):
FUKUHARA Tatsuro
(Miyagi Cancer Center)
,
FURUYA Naoki
(St. Marianna Univ. School of Medicine)
,
SAITO Haruhiro
(Kanagawa Cancer Center)
,
SUGAWARA Shunichi
(Sendai Kousei Hospital)
,
IWASAWA Shunichiro
(Chiba Univ. Hospital)
,
TSUNEZUKA Yoshio
(Ishikawa Prefectural Central Hospital)
,
YAMAGUCHI Ou
(Saitama Medical Univ. International Medical Center)
,
OKADA Morihito
(Hirohsima Univ.)
,
YOSHIMORI Kozo
(Director of Clinical Cancer Center Fukujuji Hospital.)
,
NAKACHI Ichiro
(Saiseikai Utsunomiya Hospital)
,
HAGIWARA Koichi
(Jichi Medical Univ.)
,
NUKIWA Toshihiro
(Tohoku Univ.)
,
MORITA Satoshi
(Kyoto Univ. Graduate School of Medicine)
,
KOBAYASHI Kunihiko
(Saitama Medical Univ. International Medical Center)
,
MAEMONDO Makoto
(Iwate Medical Univ.)
資料名:
日本臨床腫瘍学会学術集会(CD-ROM)
(Program and Abstracts. Annual Meeting of Japanese Society of Medical Oncology (CD-ROM))
巻:
16th
ページ:
ROMBUNNO.PS-1
発行年:
2018年
JST資料番号:
L7804B
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)